rofecoxib

Spelling & Dictionary Insight

The English entry for rofecoxib is 9 letters long, classified as a noun, and transcribed in the International Phonetic Alphabet as /ˌɹoʊ.fəˈkɑk.sɪb/. It sits outside the most-frequent rank tiers, which is often why uncommon words generate more spelling variants per reader. The dominant gloss from Wiktionary reads: "A COX-2 inhibitor C₁₇H₁₄O₄S (trademark Vioxx) used to relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis, to manage acute pain in adults, and to treat primary dysmenorrhea bu...".

No misspelling variants are generated for rofecoxib in our index, suggesting the orthography follows predictable English patterns. It is not paired with a close-neighbour confusable in our dataset, which tends to mean the word is visually distinctive enough to stand on its own.

Etymologically, the entry records: From rofe- (of unknown origin) + -coxib (“selective cyclo-oxygenase inhibitor”). Root origin matters for spelling because borrowed morphemes (Greek, Latin, Old French, Old English) carry their source-language orthographic conventions into modern English, which is why historical etymology is often the cleanest predictor of whether a cluster like "-ough", "-eau", or "-tion" will appear. For readers arriving here from a spelling check, the authoritative guidance is: the correct English form is rofecoxib, spelled R-O-F-E-C-O-X-I-B, and any other sequence of those letters, regardless of how natural it feels, is a misspelling in standard orthography.